These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22385323)

  • 21. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated with intrauterine growth restriction.
    Borras D; Perales-Puchalt A; Ruiz Sacedón N; Perales A
    J Obstet Gynaecol; 2014 Apr; 34(3):218-20. PubMed ID: 24484391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Predictive value of soluble vascular endothelial growth factor receptor 1 for preeclampsia in second-trimester].
    Chen Q; Zhao Y; Zou L; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):161-4. PubMed ID: 17537299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The relationship between plasma level of VEGF or soluble Flt-1 and efficacy of hepatic arterial chemotherapy in patients with liver metastasis of colorectal cancer].
    Gonda T; Okada N; Nakada H; Yokoyama M; Miyazaki T; Ishibashi K; Ishida H; Matsumoto Y; Miura T
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1841-4. PubMed ID: 17212123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exogenous soluble VEGF receptor-1 (sFlt-1) regulates Th1/Th2 cytokine production from normal placental explants via intracellular calcium.
    Xu B; Thornton C; Tooher J; Hennessy A
    Hypertens Pregnancy; 2009 Aug; 28(4):448-56. PubMed ID: 19843006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between insulin-like growth factor I, vascular endothelial growth factor and its soluble receptor 1 in umbilical serum and endothelial cells obtained from normotensive and preeclamptic pregnancies.
    Olmos A; Díaz L; Avila E; Barrera D; López-Marure R; Biruete B; Larrea F; Halhali A
    Growth Factors; 2013 Aug; 31(4):123-9. PubMed ID: 23750889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia.
    Hirokoshi K; Maeshima Y; Kobayashi K; Matsuura E; Sugiyama H; Yamasaki Y; Masuyama H; Hiramatsu Y; Makino H
    Nephron Clin Pract; 2007; 106(1):c43-50. PubMed ID: 17409768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiological distribution of placental growth factor and soluble Flt-1 in early pregnancy.
    Makrydimas G; Sotiriadis A; Savvidou MD; Spencer K; Nicolaides KH
    Prenat Diagn; 2008 Mar; 28(3):175-9. PubMed ID: 18264952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alteration and potential role of soluble fms-like tyrosine kinase receptor 1 in preeclampsia].
    Li Y; Li DH; Yao YQ; Min BH; Zhang CL; Hou XH; Huang L; Zhao HX
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):581-4. PubMed ID: 16202309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No correlation between plasma levels of vascular endothelial growth factor or its soluble receptor and acute mountain sickness.
    Schommer K; Wiesegart N; Dehnert C; Mairbäurl H; Bärtsch P
    High Alt Med Biol; 2011; 12(4):323-7. PubMed ID: 22206557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF.
    Krysiak O; Bretschneider A; Zhong E; Webb J; Hopp H; Verlohren S; Fuhr N; Lanowska M; Nonnenmacher A; Vetter R; Jankowski J; Paul M; Schönfelder G
    Circ Res; 2005 Dec; 97(12):1253-61. PubMed ID: 16269656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasoactivity to and endogenous release of vascular endothelial growth factor in the in vitro perfused human placental lobule from pregnancies complicated by preeclampsia.
    Brownbill P; Mills TA; Soydemir DF; Sibley CP
    Placenta; 2008 Nov; 29(11):950-5. PubMed ID: 18845336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates.
    Boutsikou T; Malamitsi-Puchner A; Economou E; Boutsikou M; Puchner KP; Hassiakos D
    Early Hum Dev; 2006 Apr; 82(4):235-9. PubMed ID: 16337100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
    Buhimschi CS; Norwitz ER; Funai E; Richman S; Guller S; Lockwood CJ; Buhimschi IA
    Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perfusion with magnesium sulfate increases sFlt-1 secretion only in the fetal side of placenta of women with preeclampsia.
    Eshkoli T; Holcberg G; Bronfenmacher B; Amash A; Huleihel M; Erez O
    J Matern Fetal Neonatal Med; 2013 Jan; 26(2):116-22. PubMed ID: 22928533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
    Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
    Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble and membranous vascular endothelial growth factor receptor-1 in pregnancies complicated by pre-eclampsia.
    Tripathi R; Rath G; Jain A; Salhan S
    Ann Anat; 2008 Nov; 190(5):477-89. PubMed ID: 18992679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of soluble Fms-like tyrosine kinase-1 as a biomarker of acute severe heart failure in patients with acute myocardial infarction.
    Onoue K; Uemura S; Takeda Y; Somekawa S; Iwama H; Nishida T; Morikawa Y; Nakagawa H; Tsutsumi T; Sung JH; Takemoto Y; Soeda T; Okayama S; Ishigami K; Kawata H; Horii M; Nakajima T; Saito Y
    Am J Cardiol; 2009 Dec; 104(11):1478-83. PubMed ID: 19932778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concentrations of free vascular endothelial growth factor in the maternal and foetal circulations during pregnancy: a cross-sectional study.
    Ali KZ; Burton GJ; Khalid ME; Moosa R; Abd-Alla S
    J Matern Fetal Neonatal Med; 2010 Oct; 23(10):1244-8. PubMed ID: 20044875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin-binding angiogenic factors (basic fibroblast growth factor and vascular endothelial growth factor) in early neonatal life.
    Malamitsi-Puchner A; Tziotis J; Protonotariou E; Xyni K; Sarandakou A; Creatsas G
    Pediatr Res; 1999 Jun; 45(6):877-80. PubMed ID: 10367782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers.
    Belgore FM; Lip GY; Blann AD
    Br J Biomed Sci; 2000; 57(3):207-13. PubMed ID: 11050771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.